ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The European Commission has launched an "in-depth" investigation into competitive implications of Arsenal Capital Partners' planned purchase of DSM's specialty products business (C&EN, March 10, page 14). DSM and Arsenal's Velsicol Chemical unit are two of the world's largest manufacturers of benzoic acid and sodium benzoate, used in a variety of food, pharmaceutical, and animal feed products. According to EC Competition Commissioner Neelie Kroes, the chemicals are "essential to consumers and the competitiveness of European industry, which would be harmed by a reduction of competition." The EC will make a determination by Dec. 11.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter